ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 573

Identification of Factors Associated with Magnetic Resonance Images Changes Suggestive of Axial Spondyloarthritis in the Axial Skeleton of Individuals < 45 Years – Evaluation of Data from a Large Community Study

Xenofon Baraliakos1, Adrian Richter 2, Daniel Feldmann 3, Anne Ott 3, Robin Buelow 4, Carsten Oliver Schmidt 5 and Jürgen Braun 6, 1Rheumazentrum Ruhrgebiet-Ruhr-University Bochum, Herne, Germany, Herne, Germany, 2Institute for Community Medicine, University Greifswald, and German Rheumatism Research Center, Berlin, Berlin, Germany, 3Rheumazentrum Ruhrgebiet/Ruhr University Bochum, Herne, Germany, Herne, Germany, 4Department of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany, 5Institute for Community Medicine, University Greifswald, Greifswald, Germany, 6Rheumazentrum Ruhrgebiet/Ruhr University, Herne, Germany

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: axial spondyloarthritis, MRI and bone marrow edema

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Axial Spondyloarthritis, Clinical Features

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Active (bone marrow edema, BME) and structural (fatty lesions, FL) lesions in the spinal and the sacroiliac joints (SIJ), as assessed by magnetic resonance imaging (MRI), have been described in patients with axSpA but may also occur in healthy individuals (1,2).

We assess factors associated with occurrence of BME and FL in spinal- and SIJ-MRIs in a population-based study.

Methods: Spinal- (sagittal T1/T2-) and SIJ- (semi-coronal STIR sequences) MRIs were evaluated by two trained blinded readers. MRIs were analyzed for BME (SIJ and spine) and FL (spine) ‘positive’ for axSpA. Degenerative lesions were excluded. BME was quantified using Berlin MRI scores. Clinical information included, sex, smoking (yes/no), spinal pain (NRS≥4/10 in last 3 months), CRP, HLA-B27 and body mass index (BMI) categories (WHO definition of under- (cat.1), normal (cat.2), overweight (cat.3)). Associations between clinical factors and MRI lesions were analyzed for the presence/absence of lesions using univariate logistic regression and for number and size of lesions using negative binomial count regression.

Results: MRIs of 793 participants (49.4% male, 5.7% CRP-positive, 8.4% HLA-B27+, 62.7% ever smokers) were evaluated. BME lesions were found in 136 SIJ-MRIs (17.2%) and 218 (27.5%) spinal MRIs, and FL in 645 spinal MRIs (81.3%). The median hsCRP was 0.09 [0.05-0.20] mg/dl, 45 (6.4%) had an elevated hsCRP level (cut off < 5 mg/dl); 8.9% were HLA-B27+; 62.7% reported smoking, 45.0% were in the under- or normal weight BMI category. 36.2% in the overweight and 18.8% in the obese BMI category. More and larger SIJ-BME lesions were independently associated with HLA-B27+ (exp(β)=2.8, 1.5-4.9), spinal pain (exp(β)=1.7, 1.2-2.6), and higher BMI (cat. 1 vs 3, exp(β)=1.7, 1.0-3.0). Also, more and larger spinal BME were associated with older age (exp(β)=1.5, 1.2-2.0), while more and larger spinal FL were associated with higher BMI, (cat. 1 to cat. 3 (exp(β)=1.9, 1.5-2.2), older age (exp(β)=1.6, 1.5-1.8) and male sex (exp(β)=1.4, 1.2-1.6). Presence of spinal BME (OR 1.3, 1.0±1.7) and/or spinal FL (OR 1.7, 1.3-2.3) was associated with older age, while alone were associated with a higher BMI (cat. 1 to cat.3, OR 3.3, 1.8-6.1). In total, 22 subjects (16.2%) had large ( >33% of surface involvement) and 114 had small (≤33% of surface involvement) SIJ-BME. Large SIJ-BME were found in 4.5% HLA-B27-positive vs. 2.6% HLA-B27-negative subjects (p=0.40). Overall, 35.3% quadrants with SIJ-BME was located in the upper sacral quadrant. Most SIJ lesions (83.4%) were small. For spinal BME, 42% was located in the lower (T7/8-T11/12) thoracic spine. Most spinal lesions (90.9%) were small.

Conclusion: In this large population-based study, higher numbers of large SIJ-BME lesions were significantly associated with HLA-B27, back pain and BMI. Spinal BME and FL were associated with older age, male sex and BMI but not HLA-B27. The association for HLA-B27 was only shown on the quadrant but not on the patient level.

  1. Weber U et al, Arthritis Rheumatol 2018
  2. De Winter J et al, Arthritis Rheumatol 2018

Disclosure: X. Baraliakos, AbbVie, 2, 5, 8, Abbvie, 2, 5, 8, BMS, 2, 5, 8, 9, Bristol-Myers Squibb, 2, 5, 8, Celgene, 2, 5, 8, 9, Chugai, 2, 5, 8, 9, Janssen, 2, 5, 8, 9, Lilly, 2, 8, 9, Merck, 2, 5, 8, MSD, 2, 5, 8, 9, Novartis, 2, 5, 8, 9, Novatis, 2, 5, 8, Pfizer, 2, 5, 8, 9, UCB, 2, 5, 8, 9, UCB Pharma, 2, 5, 8, Werfen, 2, 5, 8; A. Richter, None; D. Feldmann, None; A. Ott, None; R. Buelow, None; C. Schmidt, None; J. Braun, Abbott, 2, 5, AbbVie, 2, 5, 6, 8, Amgen, 2, 5, 8, Baxter, 2, 5, 8, Biogen, 2, 8, 9, BMS, 2, 5, 8, Boehringer, 2, 5, 8, Bristol-Myers Squibb, 2, 5, Celgene, 2, 3, 5, 8, Celltrion, 2, 5, 8, Centocor, 2, 5, 8, Chugai, 2, 5, 8, Eli Lilly and Company, 2, 5, 8, Hexal, 2, 5, 8, Janssen, 2, 5, 8, Johnson & Johnson, 2, 5, Medac, 2, 5, 8, MSD, 2, 5, MSD (Schering-Plough), 2, 5, 8, Mundipharma, 2, 5, 8, Mylan, 2, 5, 8, Novartis, 2, 5, 8, Pfizer, 2, 5, Pfizer (Wyeth, Hospira), 2, 5, 8, Roche, 2, 5, 8, Sanofi-Aventis, 2, 5, 8, UCB Pharma, 2, 5, 8.

To cite this abstract in AMA style:

Baraliakos X, Richter A, Feldmann D, Ott A, Buelow R, Schmidt C, Braun J. Identification of Factors Associated with Magnetic Resonance Images Changes Suggestive of Axial Spondyloarthritis in the Axial Skeleton of Individuals < 45 Years – Evaluation of Data from a Large Community Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/identification-of-factors-associated-with-magnetic-resonance-images-changes-suggestive-of-axial-spondyloarthritis-in-the-axial-skeleton-of-individuals-45-years-evaluation-of-data-from-a-large-c/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-factors-associated-with-magnetic-resonance-images-changes-suggestive-of-axial-spondyloarthritis-in-the-axial-skeleton-of-individuals-45-years-evaluation-of-data-from-a-large-c/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology